Leo Massimo, Ramer Lucas, Hassoun Jérémy, Goossens Nicolas, Spahr Laurent, Magini Giulia
Service de gastroentérologie et hépatologie, Hôpitaux universitaires de Genève, 1211 Genève 14.
Service de transplantation, Hôpitaux universitaires de Genève, 1211 Genève 14.
Rev Med Suisse. 2023 Aug 30;19(839):1563-1567. doi: 10.53738/REVMED.2023.19.839.1563.
Liver transplantation is the best treatment option for patients with end-stage liver failure, as well as for various oncological (hepatic or extrahepatic), metabolic and genetic indications. Cirrhosis and its complications represent the most frequent indication for transplantation. This treatment option should be considered for cirrhotic patients with significant liver failure, the development of hepatocellular carcinoma or when complications linked to portal hypertension appear. In view of the limited availability of organs and a waiting time on the list estimated at around one year in Switzerland, careful assessment of the risk-benefit ratio and correct timing of evaluation in a transplant center are crucial to optimize the benefits of this procedure.